ABOUT US

About Cerbios-Pharma SA

Cerbios is a privately held company located in Lugano, Switzerland, that specializes in the development and manufacture of both chemical and biological APIs for its partners world-wide. Exclusive, third-party manufacturing services are offered by the Chemical Division for HPAIs and by the Biological Division for monoclonal antibodies, recombinant proteins and pharma probiotics. Cerbios provides full CMC support to its world-wide partners, including the supply of cGMP clinical batches, registration/validation material and commercially manufactured APIs. Paramount to this is the ability to supply all of the technical documentation and support necessary for a successful registration. Cerbios’ commercial products are marketed worldwide but primarily in Europe, USA, Japan and India. More information can be found at www.cerbios.ch

 

About AGC Biologics

AGC Biologics is leading the industry among CMOs in customer satisfaction, technical excellence, and quality – Right and On Time. With six facilities in the USA, Europe, and Asia, the Company provides fully integrated biopharmaceutical development and manufacturing solutions to clients globally. The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of proteinbased therapeutics for pre-clinical, clinical trials and commercial production. The Company’s wide range of integrated services includes cell line development, bioprocess development, formulation and comprehensive analytical testing. Clients can also benefit from AGC Biologics’ proprietary CHEF1® expression system for mammalian production. More detailed information can be found at www.agcbiologics.com

 

About Oncotec Pharma Production GmbH

Oncotec Pharma is a reliable worldwide partner for the manufacturing and development of aseptically produced cytostatic drugs. Oncotec specializes in filling of cytostatic liquids and lyophilisates in vials as well as cytostatic liquids in syringes. Since its foundation in 1997, Oncotec has steadily increased production at our Dessau site. The key to market success is focus on performing manufacturing steps using leading-edge technology production equipment.The state-of-the-art technology and equipment assures that ADC processing is conducted with the highest safety and quality standards. More information can be found at www.oncotecpharma.de